肺内磨玻璃结节影肺癌的早期诊断与治疗效果研究
2020-09-02李书平
李书平


【摘 要】目的:探讨早期诊断肺内磨玻璃结节影肺癌的临床价值与治疗效果。方法:选择2014年1月-2016年1月期间我院收治的79例疑似肺内磨玻璃结节影肺癌患者为研究对象,所有患者术前均行HRCT检查,再检测肿瘤标志物如CEA、CA125、CY21-1以及NSE水平,通过ROC曲线对肺内磨玻璃结节影肺癌中NSE、CY21-1、CA125、CEA以及HRCT的诊断效能进行分析,并且给予患者手术、放化疗治疗。结果:所有患者均顺利完成检查,HRCT的诊断符合率为96.20%,;肺内磨玻璃恶性结节患者的NSE、CY21-1、CA125以及CEA水平均高于良性结节(P<0.05);同时,确诊为肺内磨玻璃结节影肺癌的24例患者均行手术、放化疗治疗,经过5年随访,患者的3年、5年存活率分别为75.0%(18/24)、41.67%(10/24)。结论:通过运用HRCT联合肿瘤标志物诊断肺内磨玻璃结节影肺癌患者的诊断效能较高,并且尽早给予患者治疗,可以使患者生存期提高。
【关键词】肺内磨玻璃结节影肺癌;CT;肿瘤标志物
【中图分类号】R197 【文献标识码】A 【文章编号】1672-3783(2020)09-0056-02
Study on the early diagnosis and treatment of lung cancer with ground glass nodules
【Abstract】Objective: To investigate the clinical value and therapeutic effect of early diagnosis of lung cancer with ground glass nodules.Methods:from January 2014 - January 2016 our hospital during the period of 79 lung cancer patients as the research object, all patients with preoperative HRCT examination, and detection of tumor markers CEA, CA125, CY21-1 and NSE levels, by ROC curve grinding glass within the lung nodules in the shadow of lung cancer, CA125, CEA, NSE, CY21-1 and HRCT in the diagnosis efficiency is analyzed, and giving patients with surgery, radiation and chemotherapy treatment.Results: All patients successfully completed the examination, HRCT diagnostic coincidence rate was 96.20%. The levels of NSE, CY21-1, CA125 and CEA in patients with pulmonary ground glass malignant nodules were higher than those with benign nodules (P<0.05). Meanwhile, all the 24 patients diagnosed with intrapulmonary ground glass nodular lung cancer received surgery, radiotherapy and chemotherapy. After 5-year follow-up, the 3-year and 5-year survival rates of the patients were 75.0% (18/24) and 41.67% (10/24), respectively.Conclusion:HRCT combined with tumor markers has a higher diagnostic efficiency in patients with ground-glass tuberous lung cancer, and early treatment can improve the survival of patients.
【Key words】ground glass nodules in lung cancer, CT, tumor markers
肺癌是比較常见的一种恶性肿瘤,其发病机制复杂,与既往肺部慢性疾病感染、电离辐射、环境接触以及长期吸烟等诸多因素有关,因为发病早期缺乏典型症状,不容易被患者察觉,大部分患者确诊时,已经为中期或晚期,其5年生存率不高。肺内磨玻璃结节影通常指的是在高分辨率CT(HRCT)检查中,具有模糊或清楚边界的肺内密度增高影,往往包括混合型磨玻璃结节、纯玻璃结节等,使临床诊断难度增加[1]。有文献报道,在肺内磨玻璃结节影肺癌患者的临床诊断中,通过联合运用肿瘤标志物和HRCT,不仅可以使早期诊断率提高,还有助于临床治疗[2]。
1 资料和方法
1.1一般资料
选择我院2014年1月-2016年1月期间收治的疑似肺内磨玻璃结节影肺癌患者79例为研究对象,年龄30-80岁,平均(54.6±12.4)岁,其中32例为女性、47例为男性。……
